Aceto acquires A&C Bio Buffer, expanding biopharma capabilities


Deal is expected to boost manufacturer’s European presence, Aceto executives say

New York-based Aceto, who provides specialty materials for the life sciences market, has acquired A&C Bio Buffer Ltd, an Irish good manufacturing practice (GMP) manufacturer of custom buffer and chemical blend products used in the manufacturing of biopharmaceutical drug products.

Aceto officials note that this deal complements Aceto’s earlier purchase of A&C in North Carolina, a manufacturer of GMP specialty excipients and custom process solutions.

“A&C Bio Buffer is a natural add-on to our acquisition of A&C and aligns with our commitments to the biopharmaceutical space,” comments Gilles Cottier, CEO of Aceto. “… Its rapid growth reflects a reputation for service and quality, which recently led to its key role in the raw material supply chain for Covid-19 vaccines. … We believe the shared lineage reflected in A&C Bio Buffer’s skills, culture and customer focus will further support our evolution as a leading supplier of critical raw materials in the life sciences sector.”



Source link

Be the first to comment

Leave a comment